CRL Deferred Revenue

Charles River Laboratories · Deferred Revenue

CRL logo

CRL Deferred Revenue

Latest reported$210.42M
CRL FY Deferred Revenue ($39.22M → $210.42M)
High-resolution chart · PNG

CRL deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Charles River Laboratories Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
210,418,000
248,322,000
241,820,000
264,259,000
219,703,000
250,186,000
204,885,000
145,139,000
117,569,000
127,731,000
81,343,000
78,124,000
54,177,000
56,422,000
56,530,000
66,905,000
72,390,000
86,707,000
102,021,000
93,197,000
116,302,000
117,490,000
30,846,000
27,029,000
22,210,000
0
0
39,216,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.